Osmotic Laxative Market Size & Share, by Product (Lactulose, Sorbitol, Magnesium Citrate, Milk of Magnesium, Polyethylene Glycol); Application (Drug Store, Retail Pharmacies, Hospital Pharmacies, Online Pharmacies); Indication (Chronic Constipation, Irritable Bowel Syndrome with Constipation, Opioid-Induced Constipation, Acute Constipation) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5378
  • Published Date: Nov 16, 2023
  • Report Format: PDF, PPT

Companies Dominating the Osmotic Laxative Market

    • GlaxoSmithKline
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Bayer AG
    • Pfizer Inc.
    • Sanofi
    • Johnson & Johnson Private Limited
    • Novartis AG
    • Procter & Gamble
    • Reckitt Benckiser Group PLC
    • Boehringer Ingelheim International GmbH
    • AstraZeneca

Browse Key Market Insights with Data Illustration:


In The News

  • Together, Bayer AG and Peking University (PKU) will accelerate scientific research on cutting-edge technologies throughout the pharmaceutical value chain and support the translation of fundamental pharmaceutical research into drug discovery and development.
  • The U.S. subsidiary of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals, and Sanofi have announced a partnership to co-develop and co-commercialize asset TEV’574, which is presently undergoing Phase 2b clinical trials for the treatment of Crohn’s disease and ulcerative colitis, two forms of inflammatory bowel disease.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5378
  • Published Date: Nov 16, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The major factors driving the growth of the market are rising geriatric population, surge in prevalence of constipation, and growth in healthcare infrastructure.

The market size of osmotic laxative is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2024-2036.

The major players in the market are GlaxoSmithKline, Bayer AG, Pfizer Inc., Sanofi, and others.

The chronic constipation segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying